Cost‐effectiveness of vorasidenib in treatment of isocitrate dehydrogenase–mutated low‐grade glioma.
Saved in:
| Title: | Cost‐effectiveness of vorasidenib in treatment of isocitrate dehydrogenase–mutated low‐grade glioma. |
|---|---|
| Authors: | Kessel, Adam C.1 (AUTHOR) kessel.adam@mayo.edu, Kim, Hayeon2 (AUTHOR), Brown, Paul D.1 (AUTHOR), Lehrer, Eric J.1 (AUTHOR), Laack, Nadia N.1 (AUTHOR), Mahajan, Anita1 (AUTHOR), Yan, Elizabeth1 (AUTHOR), Schultz, Sydney E.3 (AUTHOR), Kizilbash, Sani4 (AUTHOR), Neth, Bryan4 (AUTHOR), Sener, Ugur4 (AUTHOR), Waddle, Mark1 (AUTHOR), Breen, William G.1 (AUTHOR), Kowalchuk, Roman O.1 (AUTHOR) |
| Source: | Cancer (0008543X). Jun2026, Vol. 132 Issue 11, p1-8. 8p. |
| Database: | Academic Search Ultimate |
| ISSN: | 0008543X |
|---|---|
| DOI: | 10.1002/cncr.70463 |
